$CYDY
CytoDyn Inc.

2017 Q2 Form 10-K Financial Statement

#000119312517231500 Filed on July 20, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2017 2016 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.110M $6.759M $2.460M
YoY Change -14.23% -4.57% 60.78%
% of Gross Profit
Research & Development $5.600M $20.21M $4.020M
YoY Change 39.3% 47.15% -54.0%
% of Gross Profit
Depreciation & Amortization $90.00K $366.4K $90.00K
YoY Change 0.0% 1.32% 0.0%
% of Gross Profit
Operating Expenses $7.800M $27.33M $6.575M
YoY Change 18.62% 29.07% -36.53%
Operating Profit -$27.33M
YoY Change 29.07%
Interest Expense $970.0K $612.8K $10.00K
YoY Change 9600.0% -86.88% -100.3%
% of Operating Profit
Other Income/Expense, Net $969.9K -$612.8K $78.05K
YoY Change 1142.78% 2756.74% -124.39%
Pretax Income -$6.830M -$25.76M -$6.500M
YoY Change 5.08% 0.23% -53.57%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.830M -$25.76M -$6.497M
YoY Change 5.12% 0.23% -53.59%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$45.66K -$186.7K -$53.72K
COMMON SHARES
Basic Shares Outstanding 152.8M shares 124.5M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2017 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.780M $1.776M $9.640M
YoY Change -81.54% -81.58% 818.1%
Cash & Equivalents $1.776M $9.642M
Short-Term Investments
Other Short-Term Assets $4.350M $4.345M $1.850M
YoY Change 135.14% 134.56% 86.87%
Inventory
Prepaid Expenses $207.3K $141.7K
Receivables
Other Receivables
Total Short-Term Assets $6.121M $6.121M $11.49M
YoY Change -46.75% -46.75% 464.05%
LONG-TERM ASSETS
Property, Plant & Equipment $17.28K $17.28K $24.55K
YoY Change -29.61% -29.61% 1.39%
Goodwill
YoY Change
Intangibles $1.917M $2.267M
YoY Change -15.44% -13.37%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.935M $1.935M $2.292M
YoY Change -15.59% -15.59% -13.24%
TOTAL ASSETS
Total Short-Term Assets $6.121M $6.121M $11.49M
Total Long-Term Assets $1.935M $1.935M $2.292M
Total Assets $8.055M $8.055M $13.79M
YoY Change -41.57% -41.57% 194.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.281M $4.281M $2.468M
YoY Change 73.47% 73.47% -50.8%
Accrued Expenses $800.0K $804.2K $1.110M
YoY Change -27.93% -27.73% -29.3%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.060M $1.059M
YoY Change
Total Short-Term Liabilities $6.144M $6.144M $3.581M
YoY Change 71.59% 71.59% -66.61%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $3.010M $3.015M
YoY Change
Total Long-Term Liabilities $3.015M $3.015M $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.144M $6.144M $3.581M
Total Long-Term Liabilities $3.015M $3.015M $0.00
Total Liabilities $9.159M $9.159M $3.581M
YoY Change 155.78% 155.78% -76.71%
SHAREHOLDERS EQUITY
Retained Earnings -$123.0M -$97.23M
YoY Change 26.5% 35.94%
Common Stock $149.5K $123.3K
YoY Change 21.19% 93.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.103M -$1.103M $10.21M
YoY Change
Total Liabilities & Shareholders Equity $8.055M $8.055M $13.79M
YoY Change -41.57% -41.57% 194.62%

Cashflow Statement

Concept 2017 Q2 2017 2016 Q2
OPERATING ACTIVITIES
Net Income -$6.830M -$25.76M -$6.497M
YoY Change 5.12% 0.23% -53.59%
Depreciation, Depletion And Amortization $90.00K $366.4K $90.00K
YoY Change 0.0% 1.32% 0.0%
Cash From Operating Activities -$7.160M -$26.73M -$5.240M
YoY Change 36.64% 7.75% 23.29%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $11.11K -$10.00K
YoY Change -100.0% -6.99%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$11.11K -$10.00K
YoY Change -100.0% -6.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $8.990M
YoY Change -76.07%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.150M 18.88M 4.690M
YoY Change -75.48% -43.51% 29.2%
NET CHANGE
Cash From Operating Activities -7.160M -26.73M -5.240M
Cash From Investing Activities 0.000 -11.11K -10.00K
Cash From Financing Activities 1.150M 18.88M 4.690M
Net Change In Cash -6.010M -7.866M -560.0K
YoY Change 973.21% -191.56% -9.68%
FREE CASH FLOW
Cash From Operating Activities -$7.160M -$26.73M -$5.240M
Capital Expenditures $0.00 $11.11K -$10.00K
Free Cash Flow -$7.160M -$26.74M -$5.230M
YoY Change 36.9% 7.74% 23.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2010Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q2 cydy Collaborative Arrangement Maximum Contingent Payments Amount
CollaborativeArrangementMaximumContingentPaymentsAmount
600000
CY2016Q2 cydy Collaborative Arrangement Maximum Contingent Payments Amount
CollaborativeArrangementMaximumContingentPaymentsAmount
807000
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
152763243 shares
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2016Q3 us-gaap Fair Value Assumptions Exercise Price
FairValueAssumptionsExercisePrice
0.78
CY2016Q4 dei Entity Public Float
EntityPublicFloat
84065616
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
-10692516
CY2015Q2 us-gaap Convertible Debt
ConvertibleDebt
4862257
CY2015Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2008907
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1050060
CY2015Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
5538335
CY2015Q2 cydy Accrued Milestone Payments
AccruedMilestonePayments
2500000
CY2015Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.88
CY2015Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
31008915 shares
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
123335634 shares
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
123335634 shares
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-97225914
CY2016Q2 us-gaap Preferred Stock Value
PreferredStockValue
95
CY2016Q2 us-gaap Liabilities
Liabilities
3580681
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13786131
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2467973
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
10205450
CY2016Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
0
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
123336
CY2016Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
107307933
CY2016Q2 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
0
CY2016Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1268750
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3580681
CY2016Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
27965338
CY2016Q2 us-gaap Assets Current
AssetsCurrent
11494342
CY2016Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
3873597
CY2016Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
378321
CY2016Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
141714
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24550
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9641776
CY2016Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
9400000
CY2016Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23510608
CY2017Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
4284246
CY2017Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
216645
CY2017Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
3500000
CY2017Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
207314
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17281
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1775583
CY2016Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
0
CY2016Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2267239
CY2016Q2 us-gaap Assets
Assets
13786131
CY2016Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2231250
CY2016Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3500000
CY2016Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
35989
CY2016Q2 cydy Prepaid Service Fees Current
PrepaidServiceFeesCurrent
1710852
CY2016Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
9863492
CY2016Q2 cydy Accrued Payable And Salaries Current
AccruedPayableAndSalariesCurrent
242708
CY2016Q2 cydy Deferred Tax Assets Charitable Contributions
DeferredTaxAssetsCharitableContributions
56950
CY2016Q2 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
870000
CY2016Q2 cydy Pre Launch Inventory
PreLaunchInventory
0
CY2016Q2 cydy Deferred Tax Assets Liabilities Net Property Plant And Equipment
DeferredTaxAssetsLiabilitiesNetPropertyPlantAndEquipment
-1236
CY2016Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.83
CY2016Q2 cydy Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
147098
CY2016Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
63307150 shares
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
149468244 shares
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
149468244 shares
CY2017Q2 us-gaap Fair Value Assumptions Exercise Price
FairValueAssumptionsExercisePrice
0.60
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-122989715
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
92
CY2017Q2 us-gaap Liabilities
Liabilities
9158672
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8055438
CY2017Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3014667
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4281204
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
-1103234
CY2017Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3014667
CY2017Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
3014667
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
149468
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
121736921
CY2017Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2017Q2 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
3014667
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1618770
CY2017Q2 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
31072
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6144005
CY2017Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3014667
CY2017Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
37371819
CY2017Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1150000
CY2017Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1058611
CY2017Q2 us-gaap Assets Current
AssetsCurrent
6120938
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-26732468
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1204791
CY2017Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1500000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
350000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
350000
CY2017Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
32530436
CY2017Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
0
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
350000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
350000
CY2017Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1917219
CY2017Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
95600000
CY2017Q2 us-gaap Assets
Assets
8055438
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
350000
CY2017Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1881230
CY2017Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3500000
CY2017Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
35989
CY2017Q2 cydy Prepaid Service Fees Current
PrepaidServiceFeesCurrent
4138041
CY2017Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
40250
CY2017Q2 cydy Accrued Payable And Salaries Current
AccruedPayableAndSalariesCurrent
637190
CY2017Q2 cydy Stock Options And Warrants Outstanding Exercisable Number
StockOptionsAndWarrantsOutstandingExercisableNumber
74535543 shares
CY2017Q2 cydy Deferred Tax Assets Charitable Contributions
DeferredTaxAssetsCharitableContributions
25500
CY2017Q2 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
167000
CY2017Q2 cydy Placement Agent Warrants Fair Value
PlacementAgentWarrantsFairValue
819200
CY2017Q2 cydy Pre Launch Inventory
PreLaunchInventory
0
CY2017Q2 cydy Deferred Tax Assets Liabilities Net Property Plant And Equipment
DeferredTaxAssetsLiabilitiesNetPropertyPlantAndEquipment
1300
CY2017Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.86
CY2017Q2 cydy Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
186772
CY2017Q2 cydy Stock Options And Warrants Outstanding Exercisable Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingExercisableAggregateIntrinsicValue
40250
CY2017Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
77859626 shares
CY2017Q2 cydy Stock Options And Warrants Outstanding Exercisable Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingExercisableWeightedAverageExercisePrice
0.85
CY2017Q2 cydy Deferred Tax Assets Tax Deferred Capitalized Debt Issuance Costs
DeferredTaxAssetsTaxDeferredCapitalizedDebtIssuanceCosts
157992
CY2012Q4 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3500000
CY2015Q2 cydy Fair Value Assumptions Adjusted Conversion Price
FairValueAssumptionsAdjustedConversionPrice
0.675
CY2015Q2 cydy Sale Of Common Stock Price Per Share
SaleOfCommonStockPricePerShare
0.75
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0182 pure
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.36 pure
CY2016Q3 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.00 pure
CY2016Q3 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
1.06 pure
CY2016Q3 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0120 pure
CY2016Q3 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P5Y
CY2016Q3 cydy Fair Value Inputs Probability Of Holder Requesting Cash Payment
FairValueInputsProbabilityOfHolderRequestingCashPayment
0.50 pure
CY2016Q3 cydy Fair Value Inputs Probability Of Fundamental Transaction
FairValueInputsProbabilityOfFundamentalTransaction
0.50 pure
CY2015Q4 us-gaap License Costs
LicenseCosts
600000
CY2015Q4 us-gaap License Costs
LicenseCosts
915000
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0148 pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.19 pure
CY2017Q1 cydy Class Of Warrants Or Rights Issued Expiration Date Extended
ClassOfWarrantsOrRightsIssuedExpirationDateExtended
2017-05-30
CY2015 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P2Y11M8D
CY2015 cydy Deferred Debt Issuance Costs
DeferredDebtIssuanceCosts
709000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
77859626 shares
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Document Type
DocumentType
10-K
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.357 pure
CY2017 dei Entity Central Index Key
EntityCentralIndexKey
0001175680
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2017 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
2164533
CY2017 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Reclassifications</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Certain prior year amounts shown in the accompanying consolidated financial statements have been reclassified to conform to the 2017 presentation. These reclassifications did not have any effect on total current assets, total assets, total current liabilities, total liabilities, total stockholders&#x2019; (deficit) equity, net loss or earnings per share.</p> </div>
CY2017 dei Trading Symbol
TradingSymbol
CYDY
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.00 pure
CY2017 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.00 pure
CY2017 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.94 pure
CY2017 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0171 pure
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
15167
CY2017 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
2164533
CY2017 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1804249
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25763801
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
138004461 shares
CY2017 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2017 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.00 pure
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001 pure
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-05-31
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Accelerated Filer
CY2017 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
72434
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Interest Expense
InterestExpense
612767
CY2017 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1010000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-11114
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8990000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1204791
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
366385
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2017 dei Entity Registrant Name
EntityRegistrantName
CYTODYN INC.
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P4Y3M15D
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-27330734
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-25763801
CY2017 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2492789
CY2017 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.19
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11114
CY2017 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1150000
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6758606
CY2017 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
18877389
CY2017 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
397883
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20205743
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7866193
CY2017 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
91389
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1504712
CY2017 us-gaap Operating Expenses
OperatingExpenses
27330734
CY2017 cydy Interest Expense On Conversion Inducement
InterestExpenseOnConversionInducement
72437
CY2017 cydy Common Stock Issuance Cost Incurred
CommonStockIssuanceCostIncurred
577214
CY2017 cydy Stock Options And Warrants Forfeitures And Expirations In Period
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriod
1470000 shares
CY2017 cydy Stock Options And Warrants Grants In Period Weighted Average Exercise Price
StockOptionsAndWarrantsGrantsInPeriodWeightedAverageExercisePrice
0.99
CY2017 cydy Interest Expense Related To Derivative Liability
InterestExpenseRelatedToDerivativeLiability
540330
CY2017 cydy Warrants Issued Included In Closing Costs
WarrantsIssuedIncludedInClosingCosts
1066667 shares
CY2017 cydy Stock Options And Warrants Exercised In Period Weighted Average Exercise Price
StockOptionsAndWarrantsExercisedInPeriodWeightedAverageExercisePrice
0.55
CY2017 cydy Interest Related To Warrant Extensions
InterestRelatedToWarrantExtensions
72437
CY2017 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P3Y4M24D
CY2017 cydy Fair Value Inputs Probability Of Holder Requesting Cash Payment
FairValueInputsProbabilityOfHolderRequestingCashPayment
0.50 pure
CY2017 cydy Estimated Future Unvested Option Forfeitures
EstimatedFutureUnvestedOptionForfeitures
0.00 pure
CY2017 cydy Fair Value Inputs Probability Of Fundamental Transaction
FairValueInputsProbabilityOfFundamentalTransaction
0.50 pure
CY2017 cydy Proceeds From Issuance Of Common Stock Allocated To Expense
ProceedsFromIssuanceOfCommonStockAllocatedToExpense
241986
CY2017 cydy Deferred Debt Issuance Costs
DeferredDebtIssuanceCosts
0
CY2017 cydy Effective Income Tax Rate Reconciliation Derivative Gain Loss Percent
EffectiveIncomeTaxRateReconciliationDerivativeGainLossPercent
0.028 pure
CY2017 cydy Stock Options And Warrants Grants In Period
StockOptionsAndWarrantsGrantsInPeriod
16935437 shares
CY2017 cydy Stock Options And Warrants Outstanding Exercisable Weighted Average Remaining Contractual Term
StockOptionsAndWarrantsOutstandingExercisableWeightedAverageRemainingContractualTerm
P3Y2M1D
CY2017 cydy Stock Options And Warrants Exercised In Period
StockOptionsAndWarrantsExercisedInPeriod
912961 shares
CY2017 cydy Non Cash Derivative Liability Associated With Warrants
NonCashDerivativeLiabilityAssociatedWithWarrants
5179200
CY2017 cydy Effective Income Tax Rate Reconciliation Inducement Charge
EffectiveIncomeTaxRateReconciliationInducementCharge
-0.010 pure
CY2017 cydy Stock Options And Warrants Forfeitures And Expirations In Period Weighted Average Exercise Price
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.56
CY2017 cydy Proceeds From Issuance Of Common Stock Gross
ProceedsFromIssuanceOfCommonStockGross
10000000
CY2017 cydy Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
19133755
CY2017 cydy Adjustments To Additional Paid In Capital Legal Fee With Registered Offerings
AdjustmentsToAdditionalPaidInCapitalLegalFeeWithRegisteredOfferings
-280883
CY2017 cydy Issuance Of Common Stock In Registered Direct Offering Value
IssuanceOfCommonStockInRegisteredDirectOfferingValue
14044252
CY2017 cydy Issuance Of Common Stock In Registered Direct Offering Per Share
IssuanceOfCommonStockInRegisteredDirectOfferingPerShare
0.75
CY2017 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Equity Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToEquityOffering
-1804249
CY2017 cydy Adjustments To Additional Paid In Capital Debt Discounts On Convertible Notes Payable
AdjustmentsToAdditionalPaidInCapitalDebtDiscountsOnConvertibleNotesPayable
91389
CY2017 cydy Non Cash Finance Cost Associated With Investors Warrants
NonCashFinanceCostAssociatedWithInvestorsWarrants
819200
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
63307150 shares
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.329 pure
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-24810651
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.00 pure
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
95437594 shares
CY2016 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.00 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.005 pure
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2016 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.27
CY2016 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
789140
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11949
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-584177
CY2016 us-gaap Gain Loss On Non Recourse Debt
GainLossOnNonRecourseDebt
72898
CY2016 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
646505
CY2016 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
7947342
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-21175511
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-25703612
CY2016 us-gaap Interest Paid
InterestPaid
26890
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
864817
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2353194
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
7918
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
646505
CY2016 us-gaap Stock Issued1
StockIssued1
143479
CY2016 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
1500000
CY2016 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
3915127
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25703612
CY2016 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
604625
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Interest Expense
InterestExpense
4671245
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-11949
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
2353194
CY2016 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1791967
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
361610
CY2016 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
1194887
CY2016 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3915127
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7082475
CY2016 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2016 us-gaap Interest Expense Debt
InterestExpenseDebt
118709
CY2016 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
94344
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
33414316
CY2016 us-gaap Noninterest Expense Commission Expense
NoninterestExpenseCommissionExpense
108000
CY2016 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
548619
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13731426
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8591716
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5412640
CY2016 us-gaap Operating Expenses
OperatingExpenses
21175511
CY2016 cydy Interest Expense On Conversion Inducement
InterestExpenseOnConversionInducement
1954108
CY2016 cydy Accounts Payable Extinguished Through Settlements
AccountsPayableExtinguishedThroughSettlements
72898
CY2016 cydy Stock Options And Warrants Forfeitures And Expirations In Period
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriod
490000 shares
CY2016 cydy Stock Options And Warrants Grants In Period Weighted Average Exercise Price
StockOptionsAndWarrantsGrantsInPeriodWeightedAverageExercisePrice
0.80
CY2016 cydy Stock Options And Warrants Exercised In Period Weighted Average Exercise Price
StockOptionsAndWarrantsExercisedInPeriodWeightedAverageExercisePrice
0.70
CY2016 cydy Interest Related To Warrant Extensions
InterestRelatedToWarrantExtensions
866713
CY2016 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P3Y2M12D
CY2016 cydy Effective Income Tax Rate Reconciliation Derivative Gain Loss Percent
EffectiveIncomeTaxRateReconciliationDerivativeGainLossPercent
0.009 pure
CY2016 cydy Stock Options And Warrants Grants In Period
StockOptionsAndWarrantsGrantsInPeriod
33838536 shares
CY2016 cydy Asset Purchase Agreement Aggregate Consideration Paying Period
AssetPurchaseAgreementAggregateConsiderationPayingPeriod
P10Y
CY2016 cydy License Fee
LicenseFee
300000
CY2016 cydy License Fee
LicenseFee
432000
CY2016 cydy Effective Income Tax Rate Reconciliation Loss On Debt Conversion
EffectiveIncomeTaxRateReconciliationLossOnDebtConversion
-0.008 pure
CY2016 cydy Stock Options And Warrants Exercised In Period
StockOptionsAndWarrantsExercisedInPeriod
1050301 shares
CY2016 cydy Amortization Of Debt Discounts
AmortizationOfDebtDiscounts
1791967
CY2016 cydy Effective Income Tax Rate Reconciliation Inducement Charge
EffectiveIncomeTaxRateReconciliationInducementCharge
-0.010 pure
CY2016 cydy Stock Options And Warrants Forfeitures And Expirations In Period Weighted Average Exercise Price
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.01
CY2016 cydy Amortization Of Debt Issuance Costs
AmortizationOfDebtIssuanceCosts
604625
CY2016 cydy Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
37569964
CY2016 cydy Amortization Of Discounts And Premiums On Debt Notes Net
AmortizationOfDiscountsAndPremiumsOnDebtNotesNet
329524

Files In Submission

Name View Source Status
0001193125-17-231500-index-headers.html Edgar Link pending
0001193125-17-231500-index.html Edgar Link pending
0001193125-17-231500.txt Edgar Link pending
0001193125-17-231500-xbrl.zip Edgar Link pending
cydy-20170531.xml Edgar Link completed
cydy-20170531.xsd Edgar Link pending
cydy-20170531_cal.xml Edgar Link unprocessable
cydy-20170531_def.xml Edgar Link unprocessable
cydy-20170531_lab.xml Edgar Link unprocessable
cydy-20170531_pre.xml Edgar Link unprocessable
d395273d10k.htm Edgar Link pending
d395273dex107.htm Edgar Link pending
d395273dex23.htm Edgar Link pending
d395273dex24.htm Edgar Link pending
d395273dex311.htm Edgar Link pending
d395273dex312.htm Edgar Link pending
d395273dex32.htm Edgar Link pending
d395273dex410.htm Edgar Link pending
d395273dex411.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g395273g0720044227539.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending